| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1698340A1 T-type calcium channel inhibitor |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1487836B1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate|, method for production and use thereof |
| 09/06/2006 | EP1458673B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1401275B1 Antiviral composition and treatment method |
| 09/06/2006 | EP1397145B1 Use of cox-2 inhibitors for the treatment of schizophrenia, or tic disorders |
| 09/06/2006 | EP1385513B1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1259241B8 The use of scopolamine salts |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | EP1112075B1 Compositions for the treatment of male erectile dysfunction |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1003546B1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | CN1829693A Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 09/06/2006 | CN1829689A Benzylamine derivative |
| 09/06/2006 | CN1829515A Use of tripolidine in providing refreshedness on waking |
| 09/06/2006 | CN1827633A Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827165A Animal medicine capable of increasing weight of meat chicken |
| 09/06/2006 | CN1827156A Consciousness-restoring tablet with pearl |
| 09/06/2006 | CN1827148A Health-caring essence prescription for relieving stress by massaging back acupoint to activate collaterals and relax channels |
| 09/06/2006 | CN1827135A Compound Chinese medicine for resisting-senility and prolonging life |
| 09/06/2006 | CN1827121A Preparation of safflower and its extract and their medical application in promoting tissue blood vessel regeneration |
| 09/06/2006 | CN1826985A Composition of health-caring serial dumpling with peony and preparation method therof |
| 09/06/2006 | CN1826923A Method for preparing brain-caring health-preserving instant soluble tea |
| 09/06/2006 | CN1273614C Synaptic knob association membrane protein 25 and its use |
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 09/06/2006 | CN1273465C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273449C Crystalline forms of atorvastatin |
| 09/06/2006 | CN1273173C Use of medicine for preventing and treating radiative damage |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/06/2006 | CN1273125C Application of BAPTA derivative in the preparing process of clinical medicine |
| 09/06/2006 | CN1273123C Application of (3R,4R)-delta 8-tetrahydrocannabinol)-11-acid in preparation of medicine for reducing cell proliferation |
| 09/06/2006 | CN1273121C Compounds for blocking androgen receptors |
| 09/06/2006 | CN1273120C Parasiticidal composition and methods of use |
| 09/06/2006 | CN1273106C Therapeutic patch |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101917 Mitochrondrial permeability transition pore affinity labels and modulators |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101908 Nontoxic treatment for infections from cytomegalovirus |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101897 Farnesyl transferase inhibitors |
| 09/05/2006 | US7101889 Lipase inhibiting composition |
| 09/05/2006 | US7101887 Treating neuropsycological diseases; schizophrenia, psychotic depression and mania |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 09/05/2006 | US7101865 24-sulfoximine vitamin D3 compounds |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101863 For skin, muscle, ocular or gastric mucosal healing |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101838 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| 09/05/2006 | US7101702 Fermentative preparation process for and crystal forms of cytostatics |
| 09/05/2006 | US7101689 Interleukin-18 binding proteins, their preparation and use |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | US7101539 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 09/05/2006 | US7101386 Patient temperature regulation method and apparatus |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 09/05/2006 | CA2206567C Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
| 09/05/2006 | CA2187484C Process for the preparation of enantiomerically pure imidazolyl compounds |
| 08/31/2006 | WO2006091522A2 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 08/31/2006 | WO2006091187A1 Isoflavonoids for preventing radiation- and chemotherapy- induced weight loss |
| 08/31/2006 | WO2006090935A1 Acerola fruit-derived pectin and use thereof |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090930A1 Novel combinational use of sulfonamide compound |
| 08/31/2006 | WO2006090927A1 Orexigenic action of sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ |
| 08/31/2006 | WO2006090910A1 Novel steroid glycoside, ngf-associated active substance, process for producing the same, method of screening thereof, and cerebral dysfunction preventive agent |
| 08/31/2006 | WO2006090900A1 Preventives/remedies for cancer |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |